Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
1.110
-0.030 (-2.64%)
Nov 4, 2024, 4:00 PM EST - Market closed

Processa Pharmaceuticals Statistics

Total Valuation

PCSA has a market cap or net worth of $3.61 million. The enterprise value is $950,865.

Market Cap 3.61M
Enterprise Value 950,865

Important Dates

The last earnings date was Wednesday, October 30, 2024, after market close.

Earnings Date Oct 30, 2024
Ex-Dividend Date n/a

Share Statistics

PCSA has 3.26 million shares outstanding. The number of shares has increased by 117.51% in one year.

Shares Outstanding 3.26M
Shares Change (YoY) +117.51%
Shares Change (QoQ) +9.81%
Owned by Insiders (%) 5.82%
Owned by Institutions (%) 1.38%
Float 2.89M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.01
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.97, with a Debt / Equity ratio of 0.03.

Current Ratio 3.97
Quick Ratio 2.37
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -211.71% and return on invested capital (ROIC) is -132.05%.

Return on Equity (ROE) -211.71%
Return on Assets (ROA) -113.11%
Return on Capital (ROIC) -132.05%
Revenue Per Employee n/a
Profits Per Employee -$886,642
Employee Count 13
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -84.05% in the last 52 weeks. The beta is 0.60, so PCSA's price volatility has been lower than the market average.

Beta (5Y) 0.60
52-Week Price Change -84.05%
50-Day Moving Average 1.33
200-Day Moving Average 1.86
Relative Strength Index (RSI) 32.43
Average Volume (20 Days) 29,993

Short Selling Information

The latest short interest is 163,575, so 5.02% of the outstanding shares have been sold short.

Short Interest 163,575
Short Previous Month 61,941
Short % of Shares Out 5.02%
Short % of Float 5.67%
Short Ratio (days to cover) 1.19

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -11.79M
Pretax Income -9.83M
Net Income -11.53M
EBITDA -11.79M
EBIT -11.79M
Earnings Per Share (EPS) -$4.55
Full Income Statement

Balance Sheet

The company has $2.89 million in cash and $96,844 in debt, giving a net cash position of $2.79 million or $0.86 per share.

Cash & Cash Equivalents 2.89M
Total Debt 96,844
Net Cash 2.79M
Net Cash Per Share $0.86
Equity (Book Value) 3.72M
Book Value Per Share 1.14
Working Capital 3.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$11.12 million and capital expenditures -$3,244, giving a free cash flow of -$11.12 million.

Operating Cash Flow -11.12M
Capital Expenditures -3,244
Free Cash Flow -11.12M
FCF Per Share -$3.42
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PCSA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -117.51%
Shareholder Yield -117.51%
Earnings Yield -307.74%
FCF Yield -297.01%

Analyst Forecast

The average price target for PCSA is $5.00, which is 350.49% higher than the current price. The consensus rating is "Buy".

Price Target $5.00
Price Target Difference 350.49%
Analyst Consensus Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on January 22, 2024. It was a reverse split with a ratio of 0.05:1.

Last Split Date Jan 22, 2024
Split Type Reverse
Split Ratio 0.05:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1